U.S. Markets open in 7 hrs 24 mins

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
348.83+25.35 (+7.84%)
At close: 4:00PM EDT
Sign in to post a message.
  • M
    Miguel
    Paraguay signed a contract for 2M doses of MRNA vaccines for 2022.
    Thai red cross orders 5M doses of MRNA for 2022.
    2021 orders are fully booked. MRNA's demand exceeds 2021 capacity (2021 estimates: 800M to 1B doses). Future orders will come in 2022. There's great demand, now waiting for 2QER & Bancel to confirm 2021 deliveries & give a clearer picture for 2022. But with adolescent EUA in Europe, pediatric study on going, & variants popping up, global demand isn't going away. GL LONGS.
    Bullish
  • r
    randall
    In 3 months or 3rd Quarter report Moderna will pass 500+.
    Bullish
  • r
    randall
    Perfect Storm: This year is providing Moderna with enough cash to fund several pipeline vaccines/therapies to the public marketplace. Now the vaccine is going to become a steady source of income for the foreseeable future. Not only will 2022 be 3 times the income of 2021 but revenue could possibly quadruple in 2023. Add in the fact that old school vaccines cannot change fast enough to cover new variants Moderna will be providing boosters to cover 1/2 the world population. GL LONGS, This is a once in a lifetime opportunity!
    Bullish
  • S
    Ske1974
    Just 12 more days till MRNA’s earnings! 😊
    Bullish
  • e
    eric
    I keep saying this it’s $1000 stock.
    Bullish
  • N
    NY
    Moderna Inc MRNA:NASDAQ
    EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for the Use of the Moderna COVID-19 Vaccine in Adolescents (12-17 Years of Age) in the European Union
    BusinessWire
    9:06 AM ET
    Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending marketing authorization for Moderna's COVID-19 vaccine (Spikevax) to include adolescents 12 years of age and older. Spikevax is the trade name authorized by the European Medicines Agency (EMA) for the Moderna COVID-19 vaccine.

    "The CHMP recommendation of the authorization of our COVID-19 vaccine for use in individuals 12 years of age and older in the European Union is a positive step forward toward authorization of our vaccine in this age group," said Stephane Bancel, Chief Executive Officer of Moderna. "As we hel p to combat the pandemic, we hope to be able to help get adolescents safely back to school this fall."

    Following the CHMP's positive opinion, the European Commission will be authorizing the use of the Moderna COVID-19 Vaccine in adolescents ages 12 years of age and older.
    Bullish
  • M
    Miguel
    Stanford U. School of Medicine: A 2d dose of mRNA vaccine induces a powerful boost to the whole immune system. link below.
    Researchers analyzed blood samples from vaccinated individuals, counted antibodies, measured levels of immune-signaling proteins and characterized every single gene in the genome of 242,479 separate immune cells.
    The 2d dose, caused a massive mobilization of newly discovered group of first-responder cells that are normally rare or inactive. The 2d shot does things the 1st shot doesn’t. Encouraging news, I'm sure more research needed,
    https://globehealthnews.com/second-dose-of-covid-19-vaccine-induces-a-powerful-boost-to-the-immune-system/
    Bullish
  • A
    ALBERTO
    more deals The Thai Red Cross Society (TRCS) has sealed a deal with the importer of the Moderna Covid-19 vaccine to directly procure the second-generation of the Moderna vaccine next year.
    Bullish
  • M
    Miguel
    Some recent news around the world.
    INDIA 24JUL. Discussions w/ MRNA for 2022 supply, 2021 orders are fully booked (India still receives MRNA thru WHO in 2021). MRNA also discusses future production in India. India reports 41,383 new covid cases in last 24 hrs.
    THAILAND 23JUL. Thai Armed Forces probed & criticised for seeking special allocation of MRNA vaccine for its personnel & families, as Thais are desperately seeking mRNA vaccines, now that Sinovac is proving less effective against the Delta variant (dominant variant in Thailand).
    USA 23JUL. Tulane University School of Medicine & Children’s Hospital in New Orleans are participating in a national clinical trial to test the effectiveness of MRNA’s vaccine in children ages 6 months to 11 years old.
    COLUMBIA 23JUL. 3.5 million MRNA vaccines, arriving Sunday, U.S. Embassy in Colombia tweeted Friday.
    TM BANCEL working around the clock to meet "fully booked" 2021 orders, making sales & production deals for 2022, & launched a pediatric test program, as the pandemic continues globally. GL LONGS.
    Bullish
  • r
    randall
    Price Moderna as an average Biotech stock and it's stock price. would be $625.00 right now. GO LONGS, stay strong!
    Bullish
  • S
    Siro
    Let us do some maths: 3B doses a year is $60B revenue and $35B net profit. Even with a conservative P/E miltiple of 15 for a technology growth stock, this would mean $525B market cap or $1,300/share. This without even considering the rest of the pipeline which could turn out to be much bigger than Covid
  • G
    Giancarlo
    huge amount of people migrating from novavax to Moderna... this should pump to 500...
    Bullish
  • g
    gagich
    Shares of Moderna Inc. gained 4.7% in trading on Friday after the company said that European regulators recommended authorizing its COVID-19 vaccine for teens as young as 12 years old. The European Medicines Agency's Committee for Medicinal Products for Human Use issued the recommendation; next up will be the final decision from the European Commission. I am really glad that I found https://stockhaul.today/bh8vh9 They have the best technology to find stocks and manage the trades
  • M
    Matthew
    I made a lot of money today
    Bullish
  • r
    randall
    Top stock in the S&P 500. Moderna gains $2.37 (+0.74%) and it is the top producer in the S&P 500 which averages a daily gain of 0.2%. Looks like Moderna is going to be the number #1 stock in the S&P 500 for the next two years and most likely for the next decade. Most importantly the decision makers see this stock as a long-term player in the S&P 500. GL LONGS! GO MODERNA!
    Bullish
  • N
    Neal
    Moderna Announces Establishment of New Charitable Foundation
    This is a sign of great company for a good cause.

    Announced it is establishing a new charitable foundation to promote public health, healthcare and educational opportunities, particularly in underserved populations. The Moderna Board of Directors has approved an initial up-front endowment of $50 million for the Moderna Charitable Foundation.
  • t
    terry
    350 today?
  • j
    jeff
    https://theempoweror.com/
    Once this news hits mainstream the stock could get shaky
  • M
    Matt
    400 hundred this week. fast
  • P
    Pim
    nice week longs, enjoy the weekend
    Bullish